Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00467753 · ClinicalTrials.gov registry record · NA

Oxcarbazepine Versus Placebo in Childhood Autism

A NA study of Autism, sponsored by University of Medicine and Dentistry of New Jersey.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT00467753 is a NA study of Autism that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 5 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00467753, a NA study of Autism, has completed, sponsored by University of Medicine and Dentistry of New Jersey.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

The proposed study is designed to assess the effectiveness of treatment with Oxcarbazepine vs. placebo in childhood/adolescent autism. This is a twelve-week study involving twenty subjects between the ages of five and seventeen with a diagnosis of autism.

Conditions Studied

Interventions

  • DRUG Oxcarbazepine
  • OTHER Placebo/sugar pill

Study Locations (1)

New Jersey

  • Child and Adolescent Psychiatry at the University Behavioral Healthcare Building, UMDNJ-RWJMS - Piscataway

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2006-04
Est. Completion 2011-12
Phase NA

What the Registry Record Tells You About NCT00467753

The ClinicalTrials.gov registry entry for NCT00467753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (97% lower). The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 2 interventions - of which Oxcarbazepine is the first listed.

NCT00467753 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT00467753 about?

NCT00467753 is a clinical study titled "Oxcarbazepine Versus Placebo in Childhood Autism". The proposed study is designed to assess the effectiveness of treatment with Oxcarbazepine vs. placebo in childhood/adolescent autism. This is a twelve-week study involving twenty subjects between the ages of five and seventeen with a diagnosis of autism.

What is the current status of trial NCT00467753?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2006-04. Estimated completion is 2011-12.

What conditions does trial NCT00467753 study?

This clinical trial studies the following conditions: Autism.

What interventions are being tested in trial NCT00467753?

The interventions under investigation include: Oxcarbazepine (DRUG), Placebo/sugar pill (OTHER).

Who is sponsoring clinical trial NCT00467753?

This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00467753 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.